D360 Pain Relief
Natural health product licensed in Canada
- Other names
- Pain-Ease, Real-Ease
- Licence holder
- Ignite Pharma Inc.
- NPN or DIN-HM
- 80091213
- Status
- Active licence
- Licence date
- 13 March 2019
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 2-hydroxybenzoate de méthyle Source : Salicylate de méthyle | 14 Pour cent |
| Eucalyptus globulus Source : Feuille Potency : 60 Pour cent Eucalyptol | 3.5 Pour cent |
| (E)-8-Méthyl-N-vanillyl-6-nonenamide Source : Capsaïcine | 0.075 Pour cent |
Non-medicinal ingredients
Carbomère 940, Triéthanolamine, PEG-400, (p)-hydroxybenzoate de méthyle, Eau, (p)-hydroxybenzoate de propyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | 1 Crème | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Enfants | minimum: 2 years ; maximum: 12 years | 1 Crème | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and / or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity, rashes and/or burning discomfort have been known to occur; in which case, discontinue use. If you experience pain, swelling or blistering, stop use and get medical help right away. Headache and redness have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Keep out of reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms persist or worsen, or re-occur within a few days, discontinue use and consult a health care practitioner. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking anticoagulant medications, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80091213
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.